ArticleCurrent oncology (Toronto, Ont.)2024

Complete Blood Count-Based Biomarkers as Predictors of Clinical Outcomes in Advanced Non-Small Cell Lung Cancer Patients with PD-L1 < 50% Treated with First-Line Chemoimmunotherapy.

Carlo Putzu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.